Thryv Therapeutics to Sponsor and Participate in the 2024 International SADS Foundation Family Conference in Chicago
MONTREAL, Nov. 4, 2024 /PRNewswire/ - Thryv Therapeutics Inc., a clinical-stage biotechnology company, is proud to announce its sponsorship and active participation in the 2024 International Sudden Arrhythmia Death Syndromes


